Loading... Please wait...
App Store Download on the App Store Google Play GET IT ON Google Play

CERo Therapeutics Holdings, Inc. (CERO) Stock Price, News & Analysis

Currency in USD Disclaimer
Add to Alerts
Add to Watchlist
$0.30 $0.02 (6.28%)
$0.27
$0.32
$0.27
$12.8
Track all markets on TradingView

Company brief: CERo Therapeutics Holdings, Inc. (CERO)

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

Price Target and Rating

  • $0.00
  • $0.00
  • $0.00
  • N/A
  • N/A
  • N/A
  • N/A

Profitability

  • $0.00
  • N/A
  • N/A
  • N/A
  • $0

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Latest News of CERO

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In

or
Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Sign Up With Email Address
or
Continue with Google Continue with Apple

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.